Skip to content

Mirion Technologies MIR Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$310.25M+0.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$223.17M
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$3.41M
Dropbox logo
DropboxDBX
$690.3M+0.2%
Zscaler logo
ZscalerZS
$1.7B
Mirion Technologies logo
Mirion TechnologiesMIR
$755.6M

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's convertible debt (non-current)?
Mirion Technologies (MIR) reported convertible debt (non-current) of $755.6M in Q1 2026.
What does convertible debt (non-current) mean?
This metric captures the principal value of debt instruments that are convertible into equity shares and have a maturity date exceeding one year. It represents a hybrid financing layer that provides the company with capital while potentially diluting existing shareholders upon conversion. Analyzing this figure allows investors to evaluate the company's long-term financing strategy and the potential impact of future equity dilution on earnings per share.